Last updated on December 2017

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Testicular Safety of Filgotinib in Adult Males with Moderately to Severely Active Ulcerative Colitis.

Brief description of study

This study is designed to evaluate the effect of treatment with filgotinib on testicular safety in adult males with moderately to severely active Ulcerative Colitis (UC).

Stipend range: $75o/v, $100proc

For those patients who complete the trial, they will be eligible for the long-term extension study, for up to 195 additional weeks. 

Clinical Study Identifier: TX154995

Find a site near you

Start Over

Gastroenterology Associates of Tidewater

112 Gainsborough Square; Suite 200 Chesapeake, VA USA
  Connect »